Sign in

CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company

CytoDyn Inc.

Sign in to watch
Ticker
CYDY
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
May 31
Incorporated
DE
Entity type
operating
EIN
753056237
Phone
360-980-8524
Business address
1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
Former names
CYTODYN INC, REXRAY CORP
  1. DEF 14A Proxy Proxy Statement
  2. 8-K Event Executive or director change
  3. 4 Option exercise Director acquired 4,078,774 shares (option exercise)
  4. PRER14A Other PRER14A
  5. PRE 14A Proxy Proxy Statement (Preliminary)
  6. 8-K Event Executive or director change
  7. 8-K/A Event Executive or director change
  8. 4/A Open-market sale Chairman & CMO sold 1,200,000 shares at $3.26 ($3,912,480)
  9. EFFECT Other Notice of Effectiveness
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. 4 Open-market sale Chief Medical Officer sold 1,200,000 shares at $3.26 ($3,912,480)
  12. 4 Open-market sale President & CEO sold 4,821,174 shares at an average $3.27 ($15,760,910)
  13. S-3/A Offering Registration Statement
  14. 8-K Event Other events
  15. 8-K Event Executive or director change
  16. 8-K Event Executive or director change · Regulation FD disclosure
  17. 3/A Insider 3/A
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 10-Q Report Quarterly Report

Page 26 of 71 · 1,401 filings